Diaceutics PLC - Belfast-based diagnostic commercialisation firm - Announces new partnership with US-based manufacturer of diagnostic test reference standard controls LGC SeraCare.
The partnership, it says, sees LGC SeraCare join the Diaceutics DXRX Network, the world's first end-to-end digital solution for the development and commercialisation of precision medicine diagnostics, expanding the range of test standardisation solutions available via the platform.
"By providing these critical technologies to the DXRX platform, both LGC SeraCare and Diaceutics will be able to advance their goal of enabling greater adoption of precision medicine by enabling all laboratories to provide consistently high quality testing using reference material to validate their test system, faster," company says.
Current stock price: 125p
Year-to-date change: 6.4% lower
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
Diaceutics (DXRX)